E3 ubiquitin ligase TRIM2 identified as a novel suppressor of CYP11B2 and aldosterone production
Cellular and Molecular Life Sciences · 2024
DOI: 10.1007/s00018-024-05545-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular and Molecular Life Sciences, 2024. Verfasst von Liang Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Aldosterone, Cytochrome P-450 CYP11B2, Ubiquitin-Protein Ligases, Ubiquitination. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Youth Interdisciplinary Special Fund of Zhongnan Hospital of Wuhan University, Foundation for the Author of National Excellent Doctoral Dissertation of the People's Republic of China, Science and Technology Innovation Cultivation Fund of Zhongnan Hospital of Wuhan University.
Abstract (Originalsprache)
Aldosterone-producing adenoma (APA) is a leading cause of primary aldosteronism (PA), a condition marked by excessive aldosterone secretion. CYP11B2, the aldosterone synthase, plays a critical role in aldosterone biosynthesis and the development of APA. Despite its significance, encoding regulatory mechanisms governing CYP11B2, particularly its degradation, remain poorly understood. In this study, we sought to uncover novel regulators of CYP11B2 stability by conducting a siRNA screen targeting E3 ubiquitin ligases. Our results identified TRIM2 as a key negative regulator of CYP11B2, where its overexpression led to a significant reduction in CYP11B2 protein levels and a concomitant decrease in aldosterone production in adrenal tumor cells. Mechanistically, we demonstrated that TRIM2 interacts with CYP11B2 via its RBCC domain, promoting K29/48-linked polyubiquitination and destabilization of CYP11B2. Further results revealed that TRIM2 is downregulated in APA tissues, showing differential expression between the zona glomerulosa (ZG) and zona fasciculata (ZF) of normal adrenal tissue. These findings highlight TRIM2 as a novel modulator of aldosterone synthesis through CYP11B2 degradation, offering a potential therapeutic target for APA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
- Hubei Key Laboratory of Urological Diseases, Wuhan, China.
- Hubei Clinical Research Center for Laparoscopic/Endoscopic Urologic Surgery, Wuhan, China.
- Institute of Urology, Wuhan University, Wuhan, China.
- Hubei Medical Quality Control Center for Laparoscopic/Endoscopic Urologic Surgery, Wuhan, China.
- Wuhan Clinical Research Center for Urogenital Tumors, Wuhan, China.
Förderung
- the Youth Interdisciplinary Special Fund of Zhongnan Hospital of Wuhan University
- Foundation for the Author of National Excellent Doctoral Dissertation of the People's Republic of China
- Science and Technology Innovation Cultivation Fund of Zhongnan Hospital of Wuhan University
Zitieren
APA
Chen, L., Hu, X., Wang, G., Yu, F., Dai, Z., Jian, X., Li, Y., Xiang, W., & Meng, Z. (2024). E3 ubiquitin ligase TRIM2 identified as a novel suppressor of CYP11B2 and aldosterone production. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-024-05545-0
Vancouver
Chen L, Hu X, Wang G, Yu F, Dai Z, Jian X, et al. E3 ubiquitin ligase TRIM2 identified as a novel suppressor of CYP11B2 and aldosterone production. Cellular and Molecular Life Sciences. 2024. doi:10.1007/s00018-024-05545-0
BibTeX
@article{Chen2024,
author = {Chen, Liang and Hu, Xuan and Wang, Gang and Yu, Fang and Dai, Zhe and Jian, Xiaobin and Li, Yong and Xiang, Wan and Meng, Zhe},
title = {E3 ubiquitin ligase TRIM2 identified as a novel suppressor of CYP11B2 and aldosterone production},
journal = {Cellular and Molecular Life Sciences},
year = {2024},
doi = {10.1007/s00018-024-05545-0}
}
EUVIMED